Biospace news

Syndicate content
RSS Feed for Biotech, Pharmaceutical and Clinical Research News | BioSpace (Generated by New Sloth)
URL: https://www.biospace.com/news/
Updated: 2 days 20 hours ago

As Autism Cases Rise, Biopharma Springs Into Action

Mon, 04/29/2024 - 02:00
As Autism Cases Rise, Biopharma Springs Into Action 4/29/2024

5 Mid-Stage ALS Drugs to Watch

Mon, 04/29/2024 - 02:00
5 Mid-Stage ALS Drugs to Watch 4/29/2024

Opinion: Larimar Could Compete with Biogen in Friedreich’s Ataxia

Mon, 04/29/2024 - 02:00
Opinion: Larimar Could Compete with Biogen in Friedreich’s Ataxia 4/29/2024

AbbVie Raises 2024 Profit Outlook, Reports Strong Q1 Sales for Skyrizi and Rinvoq

Fri, 04/26/2024 - 02:00
AbbVie Raises 2024 Profit Outlook, Reports Strong Q1 Sales for Skyrizi and Rinvoq 4/26/2024

Pfizer Secures FDA Approval for Hemophilia B Gene Therapy, Launches Warranty

Fri, 04/26/2024 - 02:00
Pfizer Secures FDA Approval for Hemophilia B Gene Therapy, Launches Warranty 4/26/2024

Gilead Touts 5% Revenue Jump, Positions for 2024 Growth and Culls Pipeline

Fri, 04/26/2024 - 02:00
Gilead Touts 5% Revenue Jump, Positions for 2024 Growth and Culls Pipeline 4/26/2024

GSK Sues Pfizer and BioNTech Over Alleged COVID-19 Patent Infringement

Fri, 04/26/2024 - 02:00
GSK Sues Pfizer and BioNTech Over Alleged COVID-19 Patent Infringement 4/26/2024

Cigna’s Evernorth to Offer Humira Biosimilar with No Out-of-Pocket Cost

Fri, 04/26/2024 - 02:00
Cigna’s Evernorth to Offer Humira Biosimilar with No Out-of-Pocket Cost 4/26/2024

BMS Decision to Lay Off 2,200 Employees Comes After M&A Spending Spree

Fri, 04/26/2024 - 02:00
BMS Decision to Lay Off 2,200 Employees Comes After M&A Spending Spree 4/26/2024

Tessera Cuts Dozens of Jobs Following Positive Preclinical Results

Fri, 04/26/2024 - 02:00
Tessera Cuts Dozens of Jobs Following Positive Preclinical Results 4/26/2024

BMS to Cut 2,200 Jobs in $1.5B Restructuring as Opdivo Sales Drop in Q1

Thu, 04/25/2024 - 02:00
BMS to Cut 2,200 Jobs in $1.5B Restructuring as Opdivo Sales Drop in Q1 4/25/2024

Merck Gets Q1 Beat as Sales of Cancer Blockbuster Keytruda Jump 20%

Thu, 04/25/2024 - 02:00
Merck Gets Q1 Beat as Sales of Cancer Blockbuster Keytruda Jump 20% 4/25/2024

Sanders Launches Probe of ‘Outrageously High Prices’ of Novo’s Ozempic, Wegovy

Thu, 04/25/2024 - 02:00
Sanders Launches Probe of ‘Outrageously High Prices’ of Novo’s Ozempic, Wegovy 4/25/2024

Regeneron Pays Mammoth $100M to Access CRISPR Enzymes for AAV Delivery

Thu, 04/25/2024 - 02:00
Regeneron Pays Mammoth $100M to Access CRISPR Enzymes for AAV Delivery 4/25/2024

Sanofi and AstraZeneca Scrap Several Early-Stage Programs in Q1

Thu, 04/25/2024 - 02:00
Sanofi and AstraZeneca Scrap Several Early-Stage Programs in Q1 4/25/2024

FTC’s Noncompete Ban Makes Switching Biopharma Jobs Easier

Thu, 04/25/2024 - 02:00
FTC’s Noncompete Ban Makes Switching Biopharma Jobs Easier 4/25/2024

FDA Approves UTILITY’s New Antibiotic for Uncomplicated UTI in Women

Thu, 04/25/2024 - 02:00
FDA Approves UTILITY’s New Antibiotic for Uncomplicated UTI in Women 4/25/2024

7 Types of Difficult Bosses and How to Deal With Them

Thu, 04/25/2024 - 02:00
7 Types of Difficult Bosses and How to Deal With Them 4/25/2024

Why Biopharma Companies Avoid Hiring People Who Need Visas

Thu, 04/25/2024 - 02:00
Why Biopharma Companies Avoid Hiring People Who Need Visas 4/25/2024

Where Do We Go From Here? The Future of Women's Health

Thu, 04/25/2024 - 02:00
Where Do We Go From Here? The Future of Women's Health 4/25/2024